How to Find a Clinical Trial for Your Retinal Disease
Finding a Retinal Disease Trial at a Glance
Looking for a clinical trial for a retina disease? Start with a free website run by the government, called ClinicalTrials.gov. You can search it by your eye problem and by how far you can travel. In the United States, every trial must be listed with the National Institutes of Health, and the studies are gathered in one place you can search at ClinicalTrials.gov.1 Next, ask your own retina doctor. They know your eyes and can point you to studies close by. You do not have to do this alone. And looking into a trial never means you have to join one.
This page explains what a clinical trial actually is, exactly where to search for retina studies, how enrollment and eligibility work, and how to weigh the possible benefits against the real limits of experimental care. It is written for the person who has a diagnosis like age-related macular degeneration, diabetic retinopathy, retinitis pigmentosa, or another inherited retinal disease and is wondering whether a study could help. Each clinical trial has its own criteria describing who can join.2
A trial is research, not a guaranteed treatment. Some participants receive an experimental therapy that may or may not help, and studying it carefully is how the field learns what works. Each study tries to find better ways to prevent, screen for, diagnose, or treat a disease.3 Going in with clear expectations, and with your regular eye doctor still in the picture, is the way to get the most out of the process while protecting yourself.
What a Clinical Trial Actually Is
A clinical trial is a carefully planned study that tests a new medical approach in people to see how safe and how helpful it is. A clinical trial is a research study that tests how well new medical approaches work in people.3 Every trial follows a written plan. Every clinical trial has a protocol, an action plan that describes what will be done in the study, how it will be conducted, and why each part is necessary.3 For retinal disease, that approach might be a new eye injection, a gene therapy, an implanted device, or a drop.
Trials move in steps so that safety is checked before a treatment reaches large numbers of people. In a Phase I trial researchers test a treatment in a small group of people for the first time; in Phase II they study it in a larger group to gauge effectiveness; in Phase III they give it to an even larger group to confirm effectiveness; and in Phase IV, after the treatment is approved and available, researchers keep tracking its safety.2 An early-phase study is smaller and focused on safety, while a later-phase study is larger and asks whether the treatment truly helps.
In many trials, chance decides which group you join. Randomization is the process by which participants are randomly assigned a treatment instead of choosing one.2 Some studies compare the new treatment against a placebo, meaning an inactive version without treatment value, so researchers can tell whether the real effect comes from the therapy. Understanding this before you enroll helps you decide whether a particular study fits what you are hoping for.
Where to Search for a Retinal Trial
ClinicalTrials.gov is the official, free registry for studies in the United States and many abroad. You can filter by condition, such as geographic atrophy or diabetic macular edema, and by distance from your home. Registered trials are listed at ClinicalTrials.gov as part of a searchable database maintained by the National Institutes of Health.1 Each listing shows the study's purpose, its eligibility rules, its locations, and a contact you can call or email.
Beyond the master database, retina organizations keep focused lists that are easier to browse. The American Society of Retina Specialists lists trials for conditions including diabetic retinopathy, age-related macular degeneration, macular hole and pucker, retinal detachment, retinopathy of prematurity, and geographic atrophy.1 For inherited retinal diseases, a patient registry can bring trials to you. The Foundation Fighting Blindness maintains the My Retina Tracker registry, which may be used to help identify clinical trial participants and can alert enrolled individuals when relevant opportunities arise.4
Your own doctor is a search tool. Retina specialists at university eye centers and large practices often run trials themselves or refer patients to colleagues who do. You should talk to your physician before deciding to participate in a clinical trial.1 Ask directly: are there studies here or nearby for my diagnosis, and would you recommend one for someone in my situation?
Many trials for inherited retinal diseases enroll only people with a specific gene change, so knowing your exact genetic diagnosis can open or close doors. The Foundation Fighting Blindness directs people with inherited retinal diseases to ClinicalTrials.gov to learn about studies underway.4 If you have an inherited condition and have never had genetic testing, ask your retina specialist whether it makes sense, both for your care and for matching you to research.
How Enrollment and Eligibility Work
Every study sets rules about who can take part, and it is normal to be screened and found ineligible for one trial while qualifying for another. Each clinical trial has criteria describing who can join, and studies enroll children, adults, patients, and healthy volunteers depending on the question being asked.2 Criteria often include your specific diagnosis, the stage of your disease, your age, and other health conditions. Being turned down for one study is not a verdict on your health; it means that trial was built to answer a narrow question.
Before you agree to anything, the study team walks you through the details in a process called informed consent, and joining is always your choice. Participation in a clinical trial is voluntary, and you may stop taking part at any time.5 You can take the consent form home, ask your retina specialist to review it, and change your mind at any point without losing your regular care.
Studies are not run without oversight. Institutional Review Boards review and monitor most clinical trials in the United States to help protect the rights and welfare of participants.5 A legitimate trial will be registered, will name its sponsor and its review board, and will never ask you to pay to receive the experimental treatment being studied. If something feels off, that is a reason to slow down and ask questions.
How Strong Is the Evidence Behind Trial Treatments
The honest framing is that a trial treatment is unproven, which is exactly why it is in a study rather than in standard care. A study answers scientific questions and tries to find better ways to prevent, screen for, diagnose, or treat a disease.3 An early-phase retina study may tell us mostly about safety, not yet whether vision improves, so read a listing's phase to gauge how much is known.
The phase is a rough guide to how much evidence already exists. A treatment reaches a Phase III trial only after earlier phases in smaller groups, and Phase III is where effectiveness is confirmed in an even larger group.2 A later-phase study for your condition generally rests on more prior evidence than a first-in-people study, though neither guarantees a personal benefit.
No trial can promise that your vision will improve, and a responsible study will not claim it can. The value of taking part is access to careful monitoring, a possible new option, and a contribution to knowledge that helps future patients. Weigh that against travel, time, and the chance of receiving a placebo before deciding.
Weighing the Benefits, Risks, and Realistic Outlook
People join retina trials for real reasons. You may gain access to a promising therapy before it is widely available, plus close monitoring by a research team, and you contribute to research that could help others with your disease. Each study tries to find better ways to prevent, screen for, diagnose, or treat a disease.3 For some people, the added attention to their eyes is a benefit on its own.
An experimental treatment can have side effects that are not yet fully known, and you may receive a placebo rather than the active therapy. Trials also ask for time: extra visits, imaging, and travel. Knowing this in advance is part of an honest decision, and the consent process exists to lay it out. The consent process explains a study's purpose and duration, its possible risks and benefits, and what your participation and care will involve.5
Most people who look into trials do so alongside, not instead of, their standard retina care. A trial is one option among several, and choosing not to join is a completely reasonable decision. Whatever you decide, keeping your regular retina appointments protects the vision you have while research continues.
When to Talk to Your Eye Doctor
The best time to raise clinical trials is at a routine visit with the retina specialist who manages your disease. Ask whether a study fits your diagnosis and stage, and whether your genetic results, if you have an inherited condition, would match you to research. You should talk to your physician before deciding to participate in a clinical trial.1 Your doctor can also help you read a consent form and understand what a study would ask of you.
Looking for a trial should never delay urgent eye care. Call your eye doctor or seek same-day care if you notice a sudden shower of new floaters, flashes of light, a curtain or shadow moving across your vision, or a sudden drop in vision. Each clinical trial has criteria describing who can join, and enrollment is a planned process, not an emergency step.2 These sudden changes can signal a retinal problem that needs treatment now, well before any research question.
A retina specialist manages retinal disease over the long term, whether or not you enroll in a study. Keep that relationship active, since your specialist coordinates your standard treatment, monitors your eyes, and is best placed to tell you when a new trial worth considering opens for your condition.
Common Questions About Retinal Disease Trials
You should not have to pay to receive the experimental treatment a trial is studying, and a legitimate study will make that clear during consent. That said, some everyday costs, like travel or time off work, may fall to you. Ask the study team directly what is covered and what is not before you enroll. A trial that asks you to pay for the experimental therapy itself is a warning sign worth raising with your retina specialist.
Maybe, depending on the study. Some trials compare a new treatment against a placebo, an inactive version, so researchers can measure the true effect. Randomization means participants are randomly assigned to a group rather than choosing one.2 The consent form will tell you whether a placebo is used and what your chances are of receiving it, so you can decide with that in mind.
Yes. Participation in a clinical trial is voluntary, and you may stop taking part at any time.5 You do not need to justify the decision, and choosing to leave should not affect the regular medical care you receive elsewhere. If you are considering stopping, it helps to tell both the study team and your own retina specialist so your ongoing eye care stays coordinated.
This is common and not a dead end. Each clinical trial has narrow criteria describing who can join.2 New studies open regularly, so a search that comes up empty today may look different in a few months. Registries such as My Retina Tracker can alert you when a matching study opens, and your retina specialist may know of trials that are not easy to find on your own.
No. Most people take part in a study while continuing their standard care, and a good study coordinates with your own doctor rather than replacing them. You should talk to your physician before deciding to participate.1 Keeping your regular appointments protects the vision you have and keeps someone accountable for your overall eye health throughout the study.
A trustworthy trial is registered, names its sponsor, and is overseen by a review board. Institutional Review Boards review and monitor most clinical trials in the United States.5 Look for the study on ClinicalTrials.gov, check that it lists a review board and a real contact, and be cautious of any program that guarantees results or charges you for the experimental treatment. Your retina specialist can help you tell a genuine study from a questionable one.
More Questions About Joining a Trial
Sometimes the closest study for your specific condition is far away, especially for rare inherited retinal diseases. Whether the travel is worth it depends on the study's phase, what it asks of you, and your own situation. A study's consent process explains its purpose, duration, and what participation will involve, including required visits.5 Ask how many trips are required and over how long, then discuss the trade-off with your retina specialist before committing.
For inherited retinal diseases, often yes. Many studies accept only people with one particular gene change, so the study team may ask for your test result before enrolling you. The Foundation Fighting Blindness points people with inherited retinal diseases to resources for learning about studies underway.4 If you have never been tested, raise it at your next appointment. Without a confirmed result, you may not be able to enter these gene-specific studies at all.
- Are there clinical trials here or nearby for my specific retinal diagnosis and stage?
- If I have an inherited retinal disease, would genetic testing help match me to a study?
- What phase is this trial, and what does that tell us about how much is already known?
- Would you recommend a trial for someone in my situation, or is standard care the better path right now?
- Can you help me review the informed consent form before I decide?
- How would joining a trial fit with the regular care you already provide?
- American Society of Retina Specialists (ASRS) (2024). Clinical Trials - Patients.
- National Heart, Lung, and Blood Institute (NHLBI, NIH) (2022). Clinical Trials - How Clinical Trials Work.
- MedlinePlus (U.S. National Library of Medicine) (2024). Clinical Trials.
- Foundation Fighting Blindness (2024). Clinical Trials.
- National Institute of Mental Health (NIMH, NIH) (2023). Clinical Research Trials and You: Questions and Answers.